Another Korean innovation for stem cell work

Work at Dr. Hwang's laboratory in Korea is not limited to work with animals (preclinical work) or with cells in isolation or cultured (in vitro). There's also a major clinical (human)component, headed by Dr. Ahn, and an ethical component headed by Dr. Jung working in Korea and Dr. Hyun in the U.S. This three-part approach to stem cell collaboration is as innovative as some of the work itself and promises to set a interesting standard for research facilities around the world. While combining animal/in vitro work with clinical work is not unusual, adding in an ethical component is. See my interview with Dr. Insoo Hyun, which is accessible from the Geneforum home page, for today's news. Marie Godfrey, PhD
Genetizen's blog